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Uhrf1 (also known as Np95) is a regulator of DNA
methylation and histone ubiquitination and plays an
important role in embryogenesis and tumorigenesis.
Here, we report that Uhrf1 is essential for invariant
natural killer T (iNKT) cell development. We found
that Uhrf1 was significantly upregulated in stage 1
iNKT cells. Targeted disruption of Uhrf1 resulted
in stage 1-specific transition defects as observed
by not only increased apoptosis, but also aberrant
effector differentiation, which eventually led to the
impaired generation of iNKT cells in Uhrf1-deficient
mice. Notably, Uhrf1 deficiency resulted in attenu-
ated activation of Akt-mTOR signaling in stage 1
iNKT cells and overexpression of active Akt rescued
iNKT cell developmental defects. Collectively, our
results suggest that Uhrf1 regulation of the Akt-
mTOR signaling pathway is required for iNKT cell
development.
INTRODUCTION
Invariant natural killer T (iNKT) cells are a specialized subset of ab
T cells that express a CD1d-restricted T cell receptor (TCR)
composed of an invariant Va14-Ja18 TCR-a chain in combina-
tion with limited TCR-b chains. This unusual TCR enables them
to recognize glycolipid antigens presented by the major histo-
compatibility complex class I-like molecule CD1d (Bendelac
et al., 2007). Upon activation, iNKT cells rapidly secrete a broad
range of cytokines thus allowing them to participate in multiple
immune diseases such as infection, cancer, and autoimmunity
(Godfrey and Kronenberg, 2004; Matsuda et al., 2008). The
multifunctional properties of iNKT cells are established during
the process of iNKT cell development (Das et al., 2010).
iNKT cells diverge from conventional ab T cells at the
CD4+CD8+ double-positive (DP) thymocytes, and their develop-
ment has been classified into four distinctive stages based on
the expression of CD24, CD44, and NK1.1 (Benlagha et al.,
2005; Bezbradica et al., 2005). Of the four developmental stages,256 Cell Reports 15, 256–263, April 12, 2016 ª2016 The Authors
This is an open access article under the CC BY-NC-ND license (http://stage 1 is considered as a critical link for controlling two key
checkpoints: self-expansion during stage 0 to stage 1 and
memory-acquisition through stage 1 to stage 2. Notably, both
self-expansion and memory acquisition are constructive physio-
logical processes that determine the size and function of a
population through cellular events including cell survival, prolifer-
ation, and differentiation (Grossman et al., 2004). However, how
these cellular events are coordinately and dynamically regulated
during stage 1 cell transition is poorly understood.
Uhrf1 (also known as Np95) is an important epigenetic regu-
lator that containsmultiple domains, including N-terminal ubiqui-
tin-like domain, the Plant Homodomain, the Set and Ring
Associated domain, and the RING domain. These domains of
Uhrf1 enable it to mediate various processes such as mainte-
nance of DNA methylation, heterochromatin organization, gene
transcription, and ubiquitination of target proteins (Bostick
et al., 2007; Xie et al., 2012). Recent research has elucidated
that Uhrf1 is upregulated in various human cancers and plays
an important role in tumorigenesis and cancer progression (Bab-
bio et al., 2012; Mudbhary et al., 2014). Moreover, Uhrf1 has
been shown to regulate cell proliferation, survival, growth, and
migration (Jeanblanc et al., 2005; Jenkins et al., 2005; Wang
et al., 2012). To investigate the role of Uhrf1 in T cell develop-
ment, we constructed the Uhrf1 conditional knockout (Uhrf1/)
mice and found that Uhrf1 specifically controls iNKT cell survival
and effector differentiation through the Akt-mTOR axis.RESULTS
Uhrf1 Is Autonomously Required for iNKT Cell
Development
To investigate the role of Uhrf1 in T cell development, we gener-
ated CD4-cre-mediated Uhrf1 conditional knockout mice (Fig-
ures S1A–S1C) and analyzed the development of conventional
ab T and NKT cells. Compared with wild-type (WT) littermates,
no significant difference could be observed with respect to
both the proportion and the absolute number of the indicated
conventional ab T cell subsets from Uhrf1/ mice (Figures
S1D and S1E). Additionally, DP thymocytes from WT and
Uhrf1/ mice expressed equal quantities of CD5, CD69, and
TCR-b (Figure S1F). These results indicated that ab T cellcreativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Uhrf1 Is Required for iNKT Cell Development
(A) Flow cytometry analysis of TCR-b and PBS-57-loaded CD1d tetramer double-positive cells in the thymus, spleen, and liver from WT and Uhrf1/ mice.
Unloaded CD1d tetramer staining served as a negative control. The specific staining of iNKT cells was verified in Figures S2A and S2B.
(B and C) The percentage (B) and absolute number (C) of iNKT cells in the thymus, spleen, and liver from WT and Uhrf1/ mice (n = 6 for each genotype).
(D and E) Flow cytometry analysis of iNKT cell developmental stages. Stage 0 cells were gated as CD24hi tetramer+ in the thymus (D). Gated stage 1–3 cells
(CD24lowtetramer+) were further analyzed based on the expression of CD44 and NK1.1 (E).
(F and G) Frequency (F) and absolute number (G) of iNKT cells at stage 0 (ST0), stage 1 (ST1), stage 2 (ST2), and stage 3 (ST3) in the thymus fromWT andUhrf1/
mice (n = 10 for each genotype).
The data are mean ± SEM, for all panels: *p < 0.05; ***p < 0.001 by Student’s t test; N.S., no significance. All data are representative of or combined from at least
three independent experiments. See also Figures S1 and S2.development was normal in Uhrf1/ mice, which is in agree-
ment with a recently published report (Obata et al., 2014). We
then evaluated iNKT cell development by staining cells with
TCR-b and CD1d tetramers. Interestingly, flow cytometry anal-
ysis revealed a significant reduction of iNKT cells in the thymus,
spleen, and liver of Uhrf1/ mice compared with their corre-
sponding WT controls (Figures 1A–1C).
Given that iNKT cell development undergoes four distinctive
stages, we sought to define the stage at which the loss of
Uhrf1 inhibited iNKT cell development. Analysis of CD24 and
CD1d tetramer revealed that both the frequency and number
of stage 0 cells were similar betweenWT andUhrf1/mice (Fig-
ures 1D, 1F, and 1G), although some events in stage 0 gate
appear to be non-specific staining (Figures S2A and S2B). We
then analyzed further developmental stages of the CD24low
CD1d tetramer+ iNKT cells. iNKT cell development was moder-
ately arrested at stage 1 and stage 2 in Uhrf1/ mice relative
to the WT littermates (Figures 1E and 1F). Consequently, the ab-solute number of stage 1, stage 2, and, in particular, stage 3 cells
was dramatically reduced in Uhrf1/ mice (Figure 1G).
To explore whether defective iNKT cell generation in Uhrf1/
mice was a cell-autonomous effect, we generated mixed bone-
marrow chimeras. Analysis of the reconstituted recipients
showed that bone marrow cells (BMCs) from Uhrf1-deficient
mice poorly reconstituted the iNKT cell compartment in the
thymus, spleen, and liver (Figures S2C–S2E). Accordingly,
iNKT cell development showed a transitional defect at stage 1
in a cell-intrinsic manner as observed in Figures 1D and 1E (Fig-
ures S2F and S2G). Thus, Uhrf1 was autonomously required for
iNKT cell development.
Uhrf1 Controls both iNKT Cell Survival and Effector
Differentiation
Uhrf1 deficiency dramatically reduced iNKT cell number, which
may result from defective cell proliferation, impaired cell sur-
vival, or aberrant differentiation. To assess these possibilities,Cell Reports 15, 256–263, April 12, 2016 257
Figure 2. Uhrf1 Controls iNKT Cell Survival
and Effector Differentiation
(A and B) Representative histograms (A) and per-
centage (B) of BrdU+ cells at each stage of iNKT
cell development (n = 6 for each genotype).
(C and D) Representative histograms (C) and fre-
quency (D) of Annexin V+ PI cells at each stage of
iNKT cell development (n = 5 for each genotype).
(E) Flow cytometry analysis of NKT1, NKT2, and
NKT17 cells in the thymus from WT and Uhrf1/
mice.
(F and G) The frequency (F) and absolute number
(G) of NKT1, NKT2, and NKT17 cells gated based
on the expression of PLZF and RORgt as shown in
(E) (n = 5 for each genotype).
The data are mean ± SEM, for all panels: *p < 0.05;
**p < 0.01; ***p < 0.001 by Student’s t test. All data
are representative of or combined from at least
three independent experiments.cell proliferation potential was first evaluated. In spite of stage 3
cells, both stage 1 and stage 2 cells in Uhrf1/ mice exhibited
almost equivalent capability to enter the cell cycle compared to
WT controls (Figures 2A and 2B). Therefore, the reduced iNKT
cell number was not the result of inefficient proliferation in
Uhrf1-deficient mice. We then tested the survival capacity of
Uhrf1-deficient iNKT cells; all stage 1, stage 2, and stage 3 cells
exhibited considerably higher ratios of apoptosis (Figures 2C
and 2D). Thus, iNKT cells were more prone to apoptosis in
Uhrf1/ mice.
Previous studies have shown that iNKT cells can differentiate
into three distinct lineages of functional effector cells (NKT1,258 Cell Reports 15, 256–263, April 12, 2016NKT2, and NKT17). Stage 3 iNKT cells
are phenotypically NKT1 cells (T-bet+
PLZFlow), whereas stage 1 and stage
2 cells consist of both NKT17 cells
(PLZFintRORgt+) and NKT2 cells
(PLZFhigh T-bet) (Carr et al., 2015; Lee
et al., 2013). The frequency of NKT1 cells
was decreased, whereas NKT2 and
NKT17 cells were increased in Uhrf1-
deficient iNKT cells relative to the WT
control (Figures 2E and 2F), and the
absolute number of all three iNKT
cell effector subsets was significantly
reduced (Figure 2G). Taken together,
these results indicated that Uhrf1 was
responsible for both iNKT cell survival
and effector differentiation.
Stage 1 Cells Exhibit Altered
Cellular Metabolism in Uhrf1/
Mice
To investigate the molecular mechanism
of Uhrf1 in regulating iNKT cell develop-
ment, we first examined the expression
pattern of Uhrf1 in different iNKT cell
stages. Remarkably, stage 1 cells ex-hibited the highest amounts of Uhrf1 transcripts relative to other
stage cells (Figure 3A). The stage-specific expression of Uhrf1
and the developmental defect at stage 1 inspired us to explore
the function of Uhrf1 during stage 1 cell progression by perform-
ing RNA sequencing (RNA-seq).
KEGG pathway analysis was performed to investigate the
functional gene clusters potentially resulting in iNKT cell devel-
opmental defects after ablation of Uhrf1. Interestingly, we found
highly enriched gene clusters related to cell metabolism such as
ribosome, oxidative phosphorylation, pyrimidine metabolism,
and purinemetabolism, as judged by KEGGpathway enrichment
results for TOP 9 enriched terms (Figure 3B).
Figure 3. Uhrf1 Deficiency Results in Altered Cellular Metabolism
(A) Relative transcription level of Uhrf1 in ST0 to ST3 cells isolated from WT mice (n = 4).
(B) Pathway enrichment analysis of differentially expressed genes (p < 0.05, fold change >2) in ST1 cells fromWT and Uhrf1/mice. The data are representative
of two independent experiments.
(C) Heatmap of key nutrient receptors differentially expressed in ST1 iNKT cells between WT and Uhrf1-deficient ST1 cells. The data are representative of two
independent experiments.
(D) Validation of Tfrc and Slc7a5 transcriptional levels in ST1 cells from WT and Uhrf1/ mice.
(E and F) Representative histograms andMean fluorescence intensity (MFI) of surface CD71 (E) and CD98 (F) in ST0 to ST3 cells fromWT andUhrf1/mice (n = 5
for each genotype).
(G) Representative histograms and MFI of 2-NBDG incorporation in ST0 to ST3 cells from WT and Uhrf1/ mice (n = 5 for each genotype).
The data are mean ± SEM, for all panels: *p < 0.05; ***p < 0.001 by Student’s t test. All data are representative of or combined from at least three independent
experiments unless otherwise indicated. See also Figure S3.Because the ability of nutrients uptake can be monitored by
the expression of key nutrient receptors (the transferrin receptor
CD71 and amino acid transporter CD98) as well as the capacityto uptake glucose (2-NBDG), which are considered as properties
of anabolic metabolism (Kelly et al., 2007), we interrogated
the RNA-seq results to assess their abundance in stage 1 cells.Cell Reports 15, 256–263, April 12, 2016 259
Notably, genes encoding CD71 (Tfrc), two subunits of CD98
(Slc3a2 and Slc7a5), and Glut3 (Slc2a3) displayed reduced
expression in stage 1 cells, whereas the gene encoding Glut1
(Slc2a1) showed slightly increased expression (Figure 3C).
Real-time PCR results validated the diminished expression of
Tfrc and Slc7a5 in Uhrf1-deficient stage 1 cells (Figure 3D).
Furthermore, flow cytometry results of Uhrf1-deficient stage 1
cells confirmed the attenuated expression of CD71 and CD98,
although the glucose uptake (2-NBDG) capacity did not alter
much, which was consistent with the RNA-seq data (Figures
3E–3G). Overexpression of CD71 or CD98 in Uhrf1-deficient
bone marrow cells failed to rescue the iNKT cell developmental
defect (Figure S4A) indicating that reduced expression of CD71
and CD98 was not the main reason for the deficiencies observed
in the absence of Uhrf1.
Uhrf1 Deficiency Leads to Impaired Activation of
Akt-mTOR Axis
Consistent with the aforementioned metabolic changes, Uhrf1-
deficient stage 1 cells exhibited a substantial contraction of
cell size, whereas the size of other stage cells was more or
less similar to that of theWT counterparts (Figure S3A). By moni-
toring cell size variation during WT iNKT cell development, we
found that stage 1 cells were obviously larger than other stage
cells (Figure S3B).
It has been well characterized that Akt-mTOR signaling
pathway can sense various environmental cues including nutrient
and growth factor availability as well as stress to regulate cell
metabolism and cell size (Shimobayashi and Hall, 2014). Notably,
CD71 and CD98 are downstream targets of the Akt-mTOR axis
(Marc¸ais et al., 2014). Considering the reduced expression of
CD71 and CD98 as well as contraction of cell size in Uhrf1-defi-
cient stage 1 cells, we measured the activation of Akt-mTOR
signaling by examining the phosphorylation status of Akt, S6
and 4EBP1 (Hay and Sonenberg, 2004). As predicted, the phos-
phorylation of Akt, S6, and 4EBP1 was considerably reduced in
a coordinated fashion in stage 1 cells but not that in other subsets
(Figures 4A–4C). As a central regulator of cell growth and meta-
bolism, Akt-mTOR signaling pathway positively regulates diverse
anabolic processes, such as protein synthesis, ribosome biogen-
esis, lipid synthesis, nucleotide biosynthesis, and nutrient uptake
(Albert andHall, 2015). Thephosphorylationpattern inconjunction
with the reduced expression of CD71 and CD98 led us to further
examine the RNA-seq results to determine whether there was ev-
idence of impaired signaling downstream of Akt-mTOR axis.
KEGG pathway analysis indicated that genes involved in nucleo-
tide biosynthesis, lipid biosynthesis, and ribosome biogenesis
were significantly downregulated in Uhrf1-deficient stage 1 cells,
whereas genes associated with glycolysis and pentose phos-
phate were moderately dysregulated (Figure S3C). Altogether,
these results suggested that the activation of Akt-mTORsignaling
pathway was impaired in Uhrf1-deficient stage 1 cells.
Overexpression of Active Akt Rescues iNKT Cell
Developmental Defects in Uhrf1-Deficient Mice
To further investigate whether the reduced activation of Akt-
mTOR axis inUhrf1-deficient stage 1 cells was a cause or conse-
quence of iNKT cell developmental defects, we performed the260 Cell Reports 15, 256–263, April 12, 2016rescue experiment by using active Akt. Constitutive expression
of active Akt fully restored iNKT cell frequency in the thymus
compared with vector control (Figures 4D and 4E). Further anal-
ysis of iNKT cell developmental stages showed the successful
transition from stage 1 to more mature stage 2 and stage 3 in
Uhrf1-deficient iNKT cells overexpressing active Akt, whereas
iNKT cell development was still arrested at stage 1 and stage 2
transfected with vector control as observed in Figure 1E (Figures
4F–4H). Interestingly, the expression level of CD71 and CD98 in
Uhrf1-deficient stage 1 iNKT cells was restored back to that of
the corresponding WT controls by overexpression of active Akt
(Figures S4B and S4C). The apoptotic ratio of active Akt-trans-
duced Uhrf1-deficient iNKT cells was almost identical to active
Akt-transduced WT iNKT cells (Figure S4D), although the histo-
gram of Annexin V was shifted, and the apoptotic ratio was
increased in active Akt-transduced iNKT cells, which may result
from the oxidative stress-induced apoptosis driven by the hyper-
activation of Akt (Los et al., 2009). Therefore, Uhrf1 facilitated
iNKT cell development by fine-tuning cellular metabolism via
the Akt-mTOR axis.
DISCUSSION
Embryonic development and tumorigenesis facilitated by Uhrf1
(Mudbhary et al., 2014; Tittle et al., 2011) via regulating DNA
methylation through Dnmt1 has been studied extensively; how-
ever, the evidence regarding the function of Uhrf1 in T cell devel-
opment and function is quite limited. Our results indicate that
Uhrf1 is specifically expressed in stage 1 iNKT cells. In the
absence of Uhrf1, iNKT cell survival is decreased and effector
differentiation is dysregulated. The Akt-mTOR signaling is atten-
uated in Uhrf1-deficient stage 1 cells, leading to altered cellular
metabolism. Importantly, overexpression of active Akt is able
to rescue iNKT cell developmental defects in the absence of
Uhrf1. Therefore, Uhrf1 is required for iNKT cell development
through the Akt-mTOR axis.
Our data reveal that cell size, properties of biosynthetic meta-
bolism, as well as Akt-mTOR signaling are all decreased specif-
ically in stage 1 iNKT cells after ablation of Uhrf1. Cell size is
considerably elevated from stage 0 to stage 1, peaking at stage
1 followed by decreasing from stage 2 to stage 3. These obser-
vations highlight the importance of metabolic control during
stage 1 cell transition. During the transition from stage 0 to stage
1, iNKT cells optimize their metabolic fitness to guarantee the en-
ergy supply for rapid growth and cell survival. Besides, stage 1
cells can subsequently progress into stage 2, during which suf-
ficient nutrients are incorporated to support protein and RNA
synthesis (Gerriets and Rathmell, 2012). Presumably, iNKT cells
in stage 1 reprogram their metabolic demands to fulfill cell sur-
vival and effector differentiation.
Our analyses reveal that both iNKT cell survival and effector
differentiation are dysregulated in stage 1 iNKT cells from
Uhrf1/ mice, which may result from attenuated Akt-mTOR
activation. Cell metabolism regarding nucleotide biosynthesis,
lipid biosynthesis, ribosome biogenesis, and nutrient uptake
is significantly reduced in Uhrf1-deficient stage 1 iNKT cells,
which may eventually lead to cell apoptosis. Thus, Akt-mTOR
axis appears to maintain the metabolic needs for cell survival.
Figure 4. Attenuated Activation of Akt-mTOR Axis Leads to an iNKT Cell Developmental Defect in Uhrf1-Deficient Mice
(A–C) Phosphorylation status of p-Akt (Ser473) (A), p-4EBP1 (Thr37 and Thr46) (B), and p-S6 (Ser236 and Ser235) (C) at each stage of iNKT cell development inWT
mice. Each MFI is normalized to the corresponding MFI of the ST1 cells from WT mice (n = 5 for each genotype).
(legend continued on next page)
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During the transition from stage 1 to stage 2, iNKT cells acquire
an effector-memory phenotype that probably requires the Akt-
mTOR axis to guarantee sufficient nutrients for differentiation.
Besides, Akt-mTOR axis has been reported to modulate the
expression of critical transcription factors for T cell differentia-
tion such as T-bet and Foxp3 (Haxhinasto et al., 2008; Rao
et al., 2010). Therefore, Akt-mTOR axis may control iNKT cell
differentiation by maintaining the metabolic demands as well
as the expression of key transcription factors. As a result, over-
expression of active Akt restores iNKT cell developmental de-
fects in Uhrf1-deficient mice. Taken together, the regulation
of Akt-mTOR axis by Uhrf1 is essential for iNKT cells to have
adequate metabolic capacity to fuel cell survival and effector
differentiation.
Ablation of mTOR complex has been reported to cause iNKT
cell defects including blockage of stage 1 cell transition and dys-
regulated effector responses, which may result from insufficient
proliferation or aberrant intracellular localization of PLZF (Prevot
et al., 2015; Shin et al., 2014; Zhang et al., 2014). Our findings
highlight that Uhrf1 regulates Akt-mTOR axis to control stage 1
cell transition bymeeting the metabolic demands for cell survival
and further effector differentiation. Taken together, we conclude
that Uhrf1-mediated fine-tuning of Akt-mTOR pathway is essen-
tial for iNKT cell development.
In summary, our study reveals that the epigenetic regulator
Uhrf1 controls two key checkpoints during stage 1 iNKT cell tran-
sition: cell survival and effector differentiation. Given the impor-
tance of iNKT cells in the immune response of both innate and
adaptive immunity, the regulation and function ofUhrf1-deficient
iNKT cells in immune diseases awaits further investigation.
EXPERIMENTAL PROCEDURES
Mice
To specifically knockout Uhrf1 in T cells, we constructed Uhrf1fl/fl mice and
bred the Uhrf1fl/fl mice with CD4-cre transgenic mice (Sun et al., 2014). All
mice were genotyped by PCR before experimentation. All animal experiments
were conducted in compliance with NIH guidelines and were approved by the
institutional animal care and use committee of the Shanghai Institutes for Bio-
logical Sciences (Chinese Academy of Sciences).
In Vivo Bromodeoxyuridine Incorporation Assay
4– 6 weekold mice were injected intraperitoneally with 1 mg bromodeoxyuri-
dine (BrdU). Ten hr later, thymocytes were stained with phycoerythrin (PE)-
CD1d-PBS-57 tetramer and enriched with a PE selection kit (STEMCELL
Technologies). Then BrdU staining was performed using the fluorescein iso-
thiocyanate (FITC) BrdU Flow kit (BD Pharmingen). BrdU incorporation into
iNKT cells was examined by flow cytometry.
Annexin V Staining
iNKT cells were enriched with PE selection kit (STEMCELL Technologies) and
then stained with surface antibodies. Subsequently, enriched iNKT cells were
stained with Annexin V staining kit (BioLegend).(D and E) Representative dot plots (D) and cell frequency (E) of iNKT cells in the
donor cells (GFP+) were shown in the representative dot plots. The data are mea
(F andG) Flow cytometry analysis of iNKT cell developmental stages in the thymus
3 cells were gated. (G) ST1 to ST3 cells were further gated based on the express
(H) Frequency of ST1, ST2, and ST3 iNKT cells in the thymus derived from from a
was performed (***p < 0.001).
All data are representative of at least three independent experiments. See also F
262 Cell Reports 15, 256–263, April 12, 2016Glucose Uptake Assessment
Total thymocytes were suspendedwith glucose-free RPMI-1640medium con-
taining 1% fetal calf serum (FCS) and 100 mM 2-NBDG (Life Technologies) and
cultured for 10 min at 37C. Cells were then surface stained for flow cytometry
analysis.
Generation of Mixed Bone Marrow Chimeras
Recipient CD45.1+mice were subjected to lethal irradiation (950 rads). Eight hr
later, BMCs from WT (CD45.1) or Uhrf1/ (CD45.2) mice were mixed with
BMCs from CD45.1+ mice at a ratio of 1:1, and a total of 3,000,000 cells
were injected intravenously into recipient mice. Mixed BM chimeric mice
were analyzed 8–10 weeks after transplantation.
Statistical Analysis
All experiments were performed for three or more times unless otherwise indi-
cated. All data were shown as mean ± SEM. To compare the statistical signif-
icance of two independent groups, Student’s t test was used unless otherwise
indicated.
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